Erick H Turner (Erick Turner)

Years Active: 2020-2023
Publications (10 Years): 5

Portland Veterans Affairs Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Portland Veterans Affairs Medical Center

United States

Staff Psychiatrist :: Mental Health and Behavioral Neurosciences

U.S. Food and Drug Administration

United States

Medical Officer :: Division of Neuropharmacological Drug Products

University of California Irvine Medical Center

United States

resident :: Psychiatry

Publications

Rosa Y Ahn-Horst, Erick H Turner
Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder. Psychological medicine (2023)
Florian Naudet, Eiko I Fried, Lisa Cosgrove, Erick H Turner, Alain Braillon, Ioana Alina Cristea
Psychedelic drugs: more emphasis on safety issues. Nature 611 (7936) (2022)
Erick H Turner, Andrea Cipriani, Toshiaki A Furawaka, Georgia Salanti, Ymkje Anna de Vries
Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials. PLoS medicine 19 (1) (2022)
Florian Naudet, Maximilian Siebert, Rémy Boussageon, Ioana Alina Cristea, Erick H Turner
An open science pathway for drug marketing authorization-Registered drug approval. PLoS medicine 18 (8) (2021)
Kimberly Turner, Andrea Carboni-Jiménez, Carla Benea, Katharine Elder, Brooke Levis, Jill Boruff, Michelle Roseman, Lisa Bero, Joel R Lexchin, Erick H Turner, Andrea Benedetti, Brett D Thombs
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ open 10 (5) (2020)

Erick H Turner.css-eqlu8i{font-size:small;padding-left:4px;} (Erick Turner)